Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Sales | 2,002,000 | 1,916,000 | 1,928,000 | 1,960,000 | 2,079,000 |
| Cost of Goods | 659,000 | 623,000 | 654,000 | 663,000 | 710,000 |
| Gross Profit | 1,343,000 | 1,293,000 | 1,274,000 | 1,297,000 | 1,369,000 |
| Operating Expenses | 995,000 | 1,042,000 | 1,043,000 | 2,783,000 | 2,600,000 |
| Operating Income | 348,000 | 251,000 | 231,000 | -1,486,000 | -1,231,000 |
| Interest Expense | 106,000 | 91,000 | 103,000 | 93,000 | 122,000 |
| Other Income | -12,000 | 3,000 | -9,000 | 4,000 | 6,000 |
| Pre-tax Income | 230,000 | 163,000 | 119,000 | -1,575,000 | -1,347,000 |
| Income Tax | -6,000 | -27,000 | 21,000 | 14,000 | -271,000 |
| Net Income Continuous | 236,000 | 190,000 | 98,000 | -1,589,000 | -1,076,000 |
| Net Income | $236,000 | $190,000 | $98,000 | $-1,589,000 | $-1,076,000 |
| EPS Basic Total Ops | 0.16 | 0.13 | 0.06 | -1.05 | -0.71 |
| EPS Basic Continuous Ops | 0.16 | 0.13 | 0.06 | -1.05 | -0.71 |
| EPS Diluted Total Ops | 0.17 | 0.12 | 0.06 | -1.05 | -0.71 |
| EPS Diluted Continuous Ops | 0.16 | 0.12 | 0.06 | -1.05 | -0.71 |
| EBITDA(a) | $348,000 | $251,000 | $231,000 | $-1,486,000 | $-1,231,000 |